HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Hypoallergenic’ Class Actions Bubbling Up: The New ‘Natural’ Scourge?

This article was originally published in The Rose Sheet

Executive Summary

There are similarities between trending “hypoallergenic” class actions and “natural” litigation that for years has been the bane of many leading brands and a cash cow for plaintiffs.

You may also be interested in...



Target, Whole Foods Have Irritated Reactions To ‘Hypoallergenic’ Product Suits

The outcomes of proposed class actions against Target Corporation and Whole Foods Market will provide bright signals as to whether plaintiffs have traction in the courts to bring false-advertising suits against “hypoallergenic” cosmetic marketers. The retailers’ motions to dismiss are pending currently.

Target, Whole Foods Have Irritated Reactions To ‘Hypoallergenic’ Product Suits

The outcomes of proposed class actions against Target Corporation and Whole Foods Market will provide bright signals as to whether plaintiffs have traction in the courts to bring false-advertising suits against “hypoallergenic” cosmetic marketers. The retailers’ motions to dismiss are pending currently.

Plaintiffs May Be Sniffing Around 'Fragrance Free,' 'Hypoallergenic' Claims

A Northwest University study recently published in JAMA Dermatology suggests that nearly half of popular “fragrance free” moisturizers actually contain fragrance, and 83% of those labeled “hypoallergenic” contain potential allergens. Media outlets reporting on the study are casting the results as evidence of deception that could endanger consumers, a message that could spur class actions.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel